End-of-day quote
Korea S.E.
23:00:00 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
20,950
KRW
|
+2.20%
|
|
+2.20%
|
-6.47%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
628,042
|
468,907
|
553,046
|
290,931
|
325,349
|
304,288
|
-
|
-
|
Enterprise Value (EV)
2 |
679.3
|
527.4
|
631.2
|
380.2
|
325.3
|
364.1
|
340.6
|
304.3
|
P/E ratio
|
28.3
x
|
41.8
x
|
19.3
x
|
-14.3
x
|
-
|
13.2
x
|
8.93
x
|
18.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.94
x
|
3.91
x
|
3.69
x
|
2.22
x
|
2.09
x
|
1.9
x
|
1.41
x
|
1.44
x
|
EV / Revenue
|
5.34
x
|
4.39
x
|
4.21
x
|
2.9
x
|
2.09
x
|
2.27
x
|
1.58
x
|
1.44
x
|
EV / EBITDA
|
15.6
x
|
13.3
x
|
13.7
x
|
43.4
x
|
-
|
7.59
x
|
5.1
x
|
5.85
x
|
EV / FCF
|
70.7
x
|
74.9
x
|
-48.9
x
|
-32.3
x
|
-
|
12.8
x
|
14.2
x
|
-
|
FCF Yield
|
1.42%
|
1.34%
|
-2.04%
|
-3.1%
|
-
|
7.83%
|
7.05%
|
-
|
Price to Book
|
4.32
x
|
2.9
x
|
2.92
x
|
1.75
x
|
-
|
1.52
x
|
1.14
x
|
1.28
x
|
Nbr of stocks (in thousands)
|
14,953
|
14,815
|
14,807
|
14,768
|
14,524
|
14,524
|
-
|
-
|
Reference price
3 |
42,000
|
31,650
|
37,350
|
19,700
|
22,400
|
20,950
|
20,950
|
20,950
|
Announcement Date
|
18/02/20
|
27/01/21
|
28/02/22
|
22/02/23
|
19/01/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
127.2
|
120.1
|
150
|
131.3
|
155.8
|
160.2
|
215.5
|
212
|
EBITDA
1 |
43.61
|
39.55
|
46.22
|
8.764
|
-
|
48
|
66.8
|
52
|
EBIT
1 |
34.77
|
30.01
|
34.8
|
-4.405
|
20.9
|
34.7
|
45.93
|
38
|
Operating Margin
|
27.34%
|
24.99%
|
23.19%
|
-3.36%
|
13.41%
|
21.66%
|
21.31%
|
17.92%
|
Earnings before Tax (EBT)
1 |
35.4
|
16.48
|
33.81
|
-21.08
|
10.41
|
21
|
46.45
|
22
|
Net income
1 |
25.6
|
11.15
|
28.12
|
-20.46
|
2.923
|
25
|
37.1
|
18
|
Net margin
|
20.13%
|
9.29%
|
18.74%
|
-15.58%
|
1.88%
|
15.61%
|
17.22%
|
8.49%
|
EPS
2 |
1,483
|
758.0
|
1,932
|
-1,380
|
-
|
1,583
|
2,347
|
1,107
|
Free Cash Flow
3 |
9,615
|
7,043
|
-12,896
|
-11,774
|
-
|
28,500
|
24,000
|
-
|
FCF margin
|
7,561.12%
|
5,866.42%
|
-8,594.97%
|
-8,966.8%
|
-
|
17,790.26%
|
11,136.89%
|
-
|
FCF Conversion (EBITDA)
|
22,049.14%
|
17,807.69%
|
-
|
-
|
-
|
59,375%
|
35,928.14%
|
-
|
FCF Conversion (Net income)
|
37,556.59%
|
63,148.88%
|
-
|
-
|
-
|
114,000%
|
64,690.03%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18/02/20
|
27/01/21
|
28/02/22
|
22/02/23
|
19/01/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
39.03
|
39.3
|
34.62
|
34.51
|
38.15
|
24.02
|
41.26
|
43.8
|
40.05
|
38.4
|
39.5
|
37.8
|
44.5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
10.01
|
3.412
|
5.255
|
1.056
|
1.071
|
-11.79
|
10.13
|
10.23
|
6.512
|
8.1
|
8.6
|
9.3
|
8.6
|
Operating Margin
|
25.64%
|
8.68%
|
15.18%
|
3.06%
|
2.81%
|
-49.07%
|
24.55%
|
23.35%
|
16.26%
|
21.09%
|
21.77%
|
24.6%
|
19.33%
|
Earnings before Tax (EBT)
|
11.17
|
2.376
|
5.04
|
3.023
|
3.218
|
-32.36
|
14.67
|
5.093
|
6.01
|
-
|
-
|
-
|
-
|
Net income
1 |
8.882
|
1.997
|
2.343
|
1.899
|
1.544
|
-26.24
|
11.31
|
2.857
|
3.454
|
5.9
|
6.9
|
8.1
|
4.2
|
Net margin
|
22.76%
|
5.08%
|
6.77%
|
5.5%
|
4.05%
|
-109.25%
|
27.42%
|
6.52%
|
8.63%
|
15.36%
|
17.47%
|
21.43%
|
9.44%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
02/11/21
|
28/02/22
|
13/05/22
|
16/08/22
|
14/11/22
|
22/02/23
|
15/05/23
|
20/07/23
|
14/11/23
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
51.3
|
58.5
|
78.2
|
89.3
|
-
|
59.9
|
36.3
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.176
x
|
1.479
x
|
1.692
x
|
10.19
x
|
-
|
1.247
x
|
0.5434
x
|
-
|
Free Cash Flow
2 |
9,615
|
7,043
|
-12,896
|
-11,774
|
-
|
28,500
|
24,000
|
-
|
ROE (net income / shareholders' equity)
|
19.5%
|
7.46%
|
16.1%
|
-11.3%
|
1.61%
|
12.1%
|
14.1%
|
7%
|
ROA (Net income/ Total Assets)
|
10.3%
|
3.84%
|
8.44%
|
-6.03%
|
-
|
5.3%
|
7.75%
|
3.4%
|
Assets
1 |
249.2
|
290.8
|
333.2
|
339.2
|
-
|
471.7
|
478.7
|
529.4
|
Book Value Per Share
3 |
9,717
|
10,913
|
12,783
|
11,237
|
-
|
13,825
|
18,436
|
16,403
|
Cash Flow per Share
3 |
657.0
|
1,299
|
427.0
|
-
|
-
|
3,360
|
3,775
|
-
|
Capex
1 |
16.3
|
11.4
|
17.4
|
10.7
|
-
|
13.6
|
15.4
|
19
|
Capex / Sales
|
12.82%
|
9.49%
|
11.62%
|
8.19%
|
-
|
8.49%
|
7.16%
|
8.96%
|
Announcement Date
|
18/02/20
|
27/01/21
|
28/02/22
|
22/02/23
|
19/01/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
20,950
KRW Average target price
36,750
KRW Spread / Average Target +75.42% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.47% | 217M | | -7.58% | 10.74B | | +2.17% | 8.93B | | +22.75% | 7.61B | | +33.99% | 5.27B | | +8.12% | 3.42B | | -8.48% | 2.86B | | -5.07% | 2.23B | | -4.22% | 2.13B | | -20.87% | 1.84B |
Medical Devices & Implants
|